Cascadian Therapeutics Inc. (CASC): Billionaire Seth Klarman’s Baupost Group Reports New Stake

Page 4 of 5 – SEC Filing
CUSIP
No. 
14740B101    
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Seth A. Klarman
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE
INSTRUCTIONS)

(a)
o
(b)
x
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
The United States of America
NUMBER OF SHARES
BENEFICIALLY  OWNED BY EACH REPORTING PERSON WITH:
5 SOLE VOTING POWER
0
6 SHARED VOTING POWER
25,000,000
7 SOLE DISPOSITIVE POWER
0
8 SHARED DISPOSITIVE POWER
25,000,000
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
25,000,000
10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (SEE INSTRUCTIONS)
o
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
18.49%
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
HC

FOOTNOTES

Follow Cascadian Therapeutics Inc. (NASDAQ:CASC)